The Forefront for Novel Therapeutic Agents Based on the Pathophysiology of Lower Urinary Tract Dysfunction: Ameliorative Effect of Solifenacin Succinate (Vesicare ®), a Bladder-Selective Antimuscarinic Agent, on Overactive Bladder Symptoms, Especially Urgency Episodes

• Päätekijät: Akiyoshi Ohtake (Tekijä), Shuichi Sato (Tekijä), Masao Sasamata (Tekijä), Keiji Miyata (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Elsevier, 2010-01-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Overactive bladder (OAB) syndrome is a common condition that is most often observed in the elderly. Pharmacological treatment with muscarinic receptor antagonists has been most widely used for OAB. An antimuscarinic agent, solifenacin, showed the highest affinity for the muscarinic M3 receptor, whic...